Researchers at Lawson Health Research Institute are leading a multi-centre registry trial to test the use of a new imaging tracer, called a PSMA tracer. Its purpose is to detect early and recurrent prostate cancer. In an official statement released by the LHSC, ...
from Google Alert - health https://ift.tt/2NuhumK
via IFTTT
0 comments:
Post a Comment